GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 942 - American Research and Competitiveness Act of 2011- provisions relating to the research and development tax credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Health Issues HCR
S. 2236 - Advancing Breakthrough Therapies for Patients Act of 2012 - provisions related to FDA regulation S. 2113 - Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act - provisions related to accelerated approval and other FDA matters S. 2289 - The Better Pharmaceuticals and Devices for Children Act - "Provisions related to amending the Federal Food, Drug, and Cosmetic Act with respect to pediatric provisions" H.R. 4274 - BPCA and PREA Reauthorization Act of 2012 - Provisions related to amending title IV of the Public Health Service Act and title V of the Federal Food, Drug, and Cosmetic Act to permanently extend the provisions of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act H.R. 4156, S. 2281- Expanding and Promoting Expertise in Rare Treatments Act of 2012 - provisions related to strengthening the FDA's ability to seek advice from external experts regarding rare diseases H.R. 3214 - Food and Drug Administration Mission Reform Act of 2011 - provisions to revise the mission of the Food and Drug Administration H.R. 4132 - FAST Act - provisions related to accelerated approval and other FDA matters H.R. 3839 - Drug Shortage Prevention Act of 2012 - provisions related to prescription drug shortages H.R. 2674 - 340B Program Improvement Act - provisions related to the 340B program PL 111-148, PL 111-152 - Patient Protection and Affordable Care Act - ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions H.R. 2405, S. 1855 - Pandemic and All Hazards Preparedness Act - provisions relating to influenza vaccine innovative technologies H.R. 4223, S. 1002 - Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act (SAFE DOSES) - provisions related to supply chain security H.R. 1483 - The Drug Safety Enhancement Act of 2011- provisions related to supply chain security H.R. 1930, S. 1799 - Access to Appropriate Immunizations for Veterans Act of 2011- provisions related to extending VA performance measure to include all federally recommended vaccine H.R. 3202 - Water Protection and Reinvestment Act - provisions pertaining to pharmaceuticals in the environment S. 3397 - Secure and Responsible Drug Disposal Act - provisions related to safe drug disposal S. 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 - provisions related to drug importation H.R. 2245, S. 296 - Preserving Access to Life-Savings Medicines Act of 2011 - provisions related to drug shortages H.R. 2939 - Pharmaceutical Stewardship Act of 2011-provisions related to drug safety H.R. 5651 - Food and Rug Administration Reform Act of 2012-provisions related to user fee reauthorization and FDA reform S. 3187 - Food and Drug Administration Safety and Innovation Act of 2012 - provisions related to user fee reauthorization and FDA reform H.R. 2529, S. 1368 - Restoring Access to Medication Act - provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts S. 1584 - Drug Safety and Accountability Act of 2011 - provisions related to drug safety No bill # assigned - Federal Food, Drug, and Cosmetic Act - section related to FDA and regulation of nicotine replacement therapies S. 1699 - Prescription Drug Cost Reduction Act - provisions related to 340B and drug rebates H.R. 3204 - Guidance Accountability and Transparency Act - provisions to set forth interpretation policy of FDA guidance No bill # assigned - USAID Child Survival Call to Action S. 1752 - Freedom to Breathe Act of 2011 -provisions relating to the removal of Essential-Use Designation for epinephrine. No bill # assigned -Efforts to amend the National Childhood Vaccine Injury Act of 1986 (26 USC 4132(N)) to include any vaccine against seasonal influenza.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| SHIRA KILCOYNE New | None |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Trade (domestic/foreign) TRD
No bill # assigned - Trans-Pacific Strategic Economic Partnership Agreement (TPP) - provisions related to intellectual property, market access and public health H.R. 6083 - Federal Agriculture Reform and Risk Management Act of 2012 -provisions related to WTO Brazil Cotton dispute S. 3240 - Agriculture Reform, Food and Jobs Act of 2012 - provisions related to WTO Brazil cotton dispute No bill # assigned - Russia Permanent Normal Trade Relations (PNTR) - "provisions related to lifting the restrictions of Title IV of the Trade Act of 1974 as they apply to Russia, which includes the freedom-of-emigration requirements of the Jackson-Vranik amendment." H.R. 6083 - Federal Agriculture Reform and Risk Management Act of 2012 - provisions related to WTO Brazil Cotton dispute S. 3240 - Agriculture Reform, Food and Jobs Act of 2012 - provisions related to WTO Brazil cotton dispute No bill # assigned - Colombia Free Trade Agreement - Implementation issues related to intellectual property, market access and public health
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| SHIRA KILCOYNE New | None |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| EDYTA WIESNER New | None |
| KIMBERLY A WILLIAMS | — |
Copyright/Patent/Trademark CPT
S. 1882 - Fair and Immediate Release of Generic Drugs Act - provisions related to patent settlements H.R. 3497 - MODDERN Cures Act of 2011 - provisions related to data protection S. 27 - Preserve Access to Affordable Generics Act - provisions related to patent settlements H.R. 741 - To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs - provisions relating to authorized generics H.R. 2182,S. 1734 - Generating Antibiotic Incentives Now Act of 2011 - provisions related to antibiotics and incentives H.R. 3261 - Stop Online Piracy Act - provisions related to anti-counterfeiting S. 373 - The Fair Prescription Drug Competition Act - provisions related to authorized generics S. 968 - Preventing Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 - provisions related to anti-counterfeiting No bill # assigned - International intellectual property issues No bill # assigned - Biopharmaceutical innovation policy issues No bill # assigned - Technical corrections to the America Invents Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Medicare/Medicaid MMM
S. 1699 - Prescription Drug Cost Reduction Act - provisions related to Medicare Part B and drug rebates H.R. 999 - Medicare Prescription Drug Savings and Choice Act of 2011- provisions related to Medicare Part D H.R. 2190 - Medicare Drug Savings Act of 2011- provisions related to Medicare Part D H.R. 452 - Medicare Decisions Accountability Act - provisions related to the Independent Payment Advisory Board (IPAB) S. 668 - Health Care Bureaucrats Elimination Act - provisions related to the Independent Payment Advisory Board (IPAB) S. 1206 - Medicare Prescription Drug Savings Act of 2011- provisions related to Medicare Part D S. 1251 -Medicare and Medicaid FAST Act - provisions related to Part D issues H.R. 1063 - Strengthening Medicare & Repaying Taxpayers Act of 2011- provisions relating to reform of Secondary Payer rules No bill # assigned - Dual eligibles coordination policy issues No bill # assigned - Deficit reduction policy issues No bill # assigned - Medicaid Program, Covered Outpatient Drugs rulemaking No bill # assigned - Medicare, Medicaid, Children's Health Insurance Programs,; Transparency Reports and Reporting of Physician Ownership or Investment Interests rulemaking
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Budget/Appropriations BUD
H.R. 5973, S. 2375 - Fiscal Year 2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act - provisions relating to Ryan White CARE Act, FDA funding H.R. 5855, S. 3216 - Fiscal Year 2013 Department of Homeland Security Appropriations Act - provisions relating to Customs and Border Protection S. 3295 - Fiscal Year 2013 Labor-HHS-Education Appropriations Act - provisions relating to Vaccine Section 317 program, Ryan White CARE Act H.R. 5857, S. 3241 - Department of State, Foreign Operations and Related Programs Appropriations Act - provisions related to funding to combat neglected tropical diseases H.R. 4966 - Sequester Replacement Act of 2012 - provisions related to overall healthcare programs, government functions, and Medicare policy changes H.R. 5652 - Sequester Replacement Reconciliation Act of 2012 - provisions related to overall healthcare programs, government functions, and Medicare policy changes
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| SHIRA KILCOYNE New | None |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.